# Medius Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medius-health-pty

- Industry: Healthcare IT
- Headquarters: Sydney, Australia
- Website: www.mediushealth.org
- Total disclosed funding: $1.2M
- Latest round: Seed (Aug 15, 2017)
- Investors on record: 1

## About

Medius Health Pty Ltd. specializes in health intelligence solutions through its innovative AI platform, optimizing risk assessments and operational efficiencies for health insurance and healthcare providers.Founded in 2017, Medius Health Pty Ltd. is a Sydney-based company that focuses on enhancing health intelligence through artificial intelligence. The company was founded by Abhi Bhatia, who serves as CEO. Medius Health raised USD 1.2 mn in Seed funding from Carthona Capital in August 2017, marking its only funding round to date.Medius Health’s core offerings center around its multi-cloud artificial intelligence platform, designed to enhance health intelligence and risk predictions using minimal health variables. The platform integrates advanced machine learning technologies and algorithms to analyze geographically specific datasets, leveraging a comprehensive medical knowledge graph to create a holistic view of population health. Key services include the proprietary UW Studio™, a complete underwriting platform that utilizes science-based ensemble models for data-driven underwriting decisions. Medius also provides pre-built AI model APIs and services that can be seamlessly integrated into existing operational workflows, addressing specific customer needs. The company primarily targets health insurance carriers, re-insurers, and healthcare providers across North America, Europe, and Asia.Medius Health generates revenue through a subscription-based model, enabling clients to access a suite of AI-driven platform services and tools. Clients, primarily consisting of insurance carriers and health providers, subscribe to specific services or integrate pre-built AI models into their operations. The transaction structure is characterized by direct business-to-business engagements, where clients pay for access to proprietary tools, including the UW Studio™ and various analytics services. The revenue model supports continuous engagement and scalability, tying client success to the effectiveness of Medius Health’s innovative solutions.Medius Health plans to leverage its recent Seed funding of USD 1.2 mn raised in August 2017 to support product development and market expansion. The company is designing new product features aimed at enhancing its AI capabilities and plans to launch these updates in the coming year. Additionally, Medius Health is targeting expansion into the European market by the end of 2024, seeking to establish partnerships with local healthcare providers and insurance carriers to broaden its reach.

## Funding rounds

- Seed, Aug 15, 2017, $1.2M — Carthona Capital

## Investors

- Carthona Capital (https://capitalatlas.ai/funds/carthona-capital) — Seed